2009 Midyear Clinical Meeting
Click here to go to the previous page
Dude, Where's My Car? Remembering What You Forgot About ID and Cardiology
Track:
Great eXpectations for New Practitioners (CE)
Program Code: 316-L01
Date: Sunday, December 6, 2009
Time: 11:30 AM to 12:30 PM EST
Location:
Venetian D, Level 2
MEETING PLANNING ASSOCIATE:
Dr. Brian Esuchanko, PharmD, Director, Educational Programs, American Society of Health-System Pharmacists
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Dr. Erstad is currently a full Professor and Assistant Department Head in the Department of Pharmacy Practice & Science at the University of Arizona College of Pharmacy. He is also a Center Investigator for the Center for Health Outcomes and Pharmacoeconomics Research and a co-director for the Arizona Clinical Research Training Program. His clinical responsibilities are performed at University Medical Center. Dr. Erstads research interests pertain to critical care medicine with an emphasis on patient safety and related outcomes research - he has authored more than 100 peer-reviewed articles and book chapters. Dr. Erstad was on the Board of Directors of the American Society of Health-System Pharmacists and has served on numerous committees and task forces for various organizations including AHRQ, USP, ISPOR, the Society of Critical Care Medicine and the American College of Chest Physicians. Dr. Erstad was the first pharmacist to receive the Society of Critical Care Medicines Shubin-Weil Master Clinician/Teacher Excellence in Bedside Teaching Award.
|
Robert Page, II,
PharmD, BCPS, Associate Professor of Clinical Pharmacy and Physical Medicine,
University of Colorado, Schools of Pharmacy & Medicine
Robert L. Page II, Pharm.D., MSPH, is an Associate Professor with the Departments of Clinical Pharmacy and Physical/Rehabilitative Medicine at the University of Colorado Denver, Schools of Pharmacy and Medicine (Aurora, CO), and the clinical pharmacy specialist for the Division of Cardiology and Heart Transplantation. Dr. Page received his Bachelors of Science in Biology and Chemistry from Furman University (Greenville, SC); Bachelors of Science in Pharmacy and Doctor of Pharmacy degrees from the Medical University of South Carolina (Charleston, SC); Masters of Science in Public Health with an Epidemiology focus from the University of Colorado School of Medicine (Denver, CO), and completed his specialty residency in pharmacotherapy from MUSC.
He is presently a Doctor of Philosophy student in Health Services Research in the Colorado School of Public Health (Aurora, Colorado). He is a Board Certified Pharmacotherapy Specialist with Added Qualifications in Cardiology, a Certified Geriatric Pharmacist, and a Fellow for the following organizations: the American College of Clinical Pharmacy, the American Heart Association (Council on Clinical Cardiology), the American Society of Consultant Pharmacists, the American Society of Health System Pharmacists, and the Society of Geriatric Cardiology. Dr. Page has authored several abstracts, journal articles, and book chapters in the areas of cardiovascular pharmacotherapy, as well as, been honored with numerous teaching awards. His research interests consist of drug-drug and drug-herbal interactions, medication adherence, and pharmacotherapy complications in the heart transplant recipient and heart failure patient.
|
Description
Planned in cooperation with the ASHP New Practitioners Forum
ACPE Activity #204-000-09-316-L01P
1.0 Contact Hour / Knowledge-based
Educational Content: General Interest
Moderator: Robert L. Page, II, PharmD, BCPS, FASHP, Associate Professor of Clinical Pharmacy and Physical Medicine, University of Colorado, Schools of Pharmacy & Medicine, Aurora; and Clinical Specialist, Division of Cardiology, University of Colorado Hospital, Aurora
11:30 a.m. – 11:35 a.m.
Announcements
11:35 a.m. – 12:00 p.m.
Don't Go Breakin' My Heart: Cardiology Pearls
Robert L. Page, II
12:00 p.m. – 12:25 p.m.
Why You Buggin'? ID Pearls
Brian L. Erstad, PharmD, FASHP, Professor, The University of Arizona, Tucson
12:25 p.m. – 12:30 p.m.
Questions, Answers, and Discussion
Learning Objectives:
LEARNER OUTCOMES:
- Discuss specific therapeutic controversies surrounding the management of the patient with cardiovascular disease.
- Discuss the measures most commonly used to determine appropriate antimicrobial prophylaxis.
- Discuss the pros and cons of commonly used resources for making antimicrobial treatment recommendations.
- Given a cardiovascular pharmacotherapy question, locate specific web-based guidelines and resource material to answer the question.
- Highlight major pharmacotherapy changes to national guidelines surrounding the managment of the patient with cardivascular disease.